HMG WORLDWIDE CORP
424B2, 1999-07-20
MISCELLANEOUS MANUFACTURING INDUSTRIES
Previous: PAK MAIL CENTERS OF AMERICA INC, 10QSB, 1999-07-20
Next: PRIMECAP MANAGEMENT CO/CA/, 13F-HR, 1999-07-20






<PAGE>




                                   PROSPECTUS

                                1,789,252 Shares

                            HMG WORLDWIDE CORPORATION

                                  Common Stock

        This is an offering of the 1,789,252 shares of common stock, par value
$.01 per share, of HMG Worldwide Corporation by certain selling stockholders. Of
the shares of common stock being offered by the selling stockholders 274,252
shares are currently owned by the selling stockholders and 1,515,000 shares may
be acquired by the selling stockholders upon exercise of certain options and
warrants issued by the Company to the selling stockholders. The Company will not
receive any proceeds from the sale of shares of common stock by the selling
stockholders.

        The selling stockholders may offer and sell the shares of common stock
from time to time, directly or through underwriters, on The Nasdaq SmallCap
Market or in the over the counter market, in negotiated transactions or
otherwise, at market prices prevailing at the time of sale, at prices related to
prevailing market prices or at negotiated prices. See "Plan of Distribution" for
a discussion of the methods of sale which the selling stockholders or their
pledgees, donees or transferees may use to offer and sell the shares.

        We have indemnified the selling stockholders against certain
liabilities, including liabilities under the Securities Act of 1933. We will
bear all expenses in connection with the registration and sales of the shares of
common stock being offered by the selling stockholders, other than any
underwriting discounts and selling commissions.

                             ----------------------

        See "Risk Factors" beginning on page 3 for a discussion of certain
factors that you should consider before you invest in the common stock being
sold by means of this prospectus.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.

                             ----------------------

        The shares of common stock being offered hereby by the selling
stockholders have not been registered for sale under the securities laws of any
state or jurisdiction as of the date of this Prospectus.

        The common stock is listed for trading on The Nasdaq SmallCap Market
under the symbol "HMGC." On July 8, 1999, the closing bid price of the common
stock as reported by The Nasdaq SmallCap Market was $4.9375 per share.

                The date of this Prospectus is July 19, 1999.



<PAGE>





                                TABLE OF CONTENTS

<TABLE>
<CAPTION>

                                                                                          PAGE
                                                                                          ----

<S>                                                                                         <C>
Where You Can Obtain Additional Information About the Company................................2
Risk Factors.................................................................................3
Use of Proceeds..............................................................................4
Selling Stockholders.........................................................................5
Plan of Distribution.........................................................................6
Legal Matters................................................................................7
Experts......................................................................................7
</TABLE>

- ----------------


          WHERE YOU CAN OBTAIN ADDITIONAL INFORMATION ABOUT THE COMPANY

        We file annual, quarterly and special reports, proxy statements and
other information with the Securities and Exchange Commission ("SEC"). You may
read and copy any of the information on file with the SEC and the SEC's public
reference rooms in Washington, D.C., New York, New York, and Chicago, Illinois.
Copies of the filed documents can be obtained by mail from the Public Reference
Section of the SEC at Room 1024, 450 Fifth Street, N.W. Washington, D.C. 20549
at prescribed rates. You may call the SEC at 1-800-SEC-0330 for further
information on the public reference rooms. Filed documents are also available to
the public at the SEC's Web site at http://www.sec.gov.

        The SEC allows us to "incorporate by reference" the information we file
with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference is
an important part of this prospectus, and information that we file later with
the SEC will automatically update and supersede this information. We incorporate
by reference the documents listed below and any future filings made with the SEC
under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934
until all of the shares offered are sold.

        (a) The Company's Annual Report on Form 10-K for its fiscal year ended
December 31, 1998;

        (b) The Company's Quarterly Report on Form 10-Q for its fiscal quarter
ended March 31, 1999; and

        (c) The Company's Registration Statement on Form 8-A for a description
of the Common Stock.

        Any statement contained in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained herein
or in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes that statement. Any
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this prospectus.

        You can request, and we will send to you, without charge, copies of
documents that are incorporated by reference in this prospectus but which are
not delivered to you (other than exhibits to such documents which are not
specifically incorporated by reference). You may request these copies by writing
or telephoning the Company at: HMG Worldwide Corporation, 475 Tenth Avenue, New
York, New York 10018, attention: Robert V. Cuddihy, Jr., telephone number (212)
736-2300.

        You should rely on the information incorporated by reference or provided
in this prospectus or any prospectus supplement. We have not authorized anyone
else to provide you with different information.


                                       2


<PAGE>


                                  RISK FACTORS

        Before you invest in the common stock, you should be aware that there
are various risks, including those described below. You should carefully
consider these risks as well as the more detailed information contained in this
prospectus and in the documents incorporated in this prospectus by reference,
before making a decision to invest in the common stock offered hereby.

THIS PROSPECTUS CONTAINS FORWARD LOOKING STATEMENTS

        Certain statements contained in this prospectus and the documents
incorporated by reference are based on current expectations. Such statements are
forward looking statements that involve a number of risks and uncertainties.
Factors that could cause actual results to differ materially include the
following: (i) general economic conditions at retail, (ii) competitive market
influences, (iii) client budgetary restrictions (iv) delays in shipment of
scheduled programs to clients (v) delay in or inability to expand the Company's
client base and/or (vi) the loss of, or reduction in spending of, existing
clients.

A SIGNIFICANT PORTION OF OUR NET REVENUES ARE DERIVED FROM A FEW MAJOR CUSTOMERS

        For the year ended December 31, 1998, Procter & Gamble and CVS/Pharmacy
accounted for approximately 12% and 11%, respectively, of the Company's net
revenue. For the year ended December 31, 1997, Bristol Meyers Squibb, Procter &
Gamble and Wal*Mart accounted for approximately 12%, 12% and 11%, respectively,
of the Company's net revenues. For the year ended December 31, 1996, Procter &
Gamble, Sara Lee International and Wal*Mart accounted for approximately 17%,
12%, and 11%, respectively, of the Company's net revenues. Although the
Company's relationship with many of its larger accounts spans several years,
none of these accounts is contractually bound to purchase the Company's products
or services. The loss of any one of such client would reduce the Company's
revenues and have a material adverse effect on the Company.

        The Company may experience changes in quarter-to-quarter net revenues
due to the timing of shipments to its clients, the effect of which may be
significant depending upon the concentration of the Company's revenues with such
clients.

OUR SUCCESS IS DEPENDENT UPON THE SERVICES OF KEY OFFICERS

        The Company's success depends, in part, upon the continued services of
Michael Wahl, Chairman of the Board and Chief Executive Officer, and certain
other key personnel. The loss of the services of any one of them could have a
material adverse effect on the Company. Although Michael Wahl is employed by the
Company pursuant to an employment agreement expiring in 2002, the Company does
not have an employment contract with any other member of senior management and
has not obtained "key-man" life insurance on the life of any member of senior
management.

WE HAVE SIGNIFICANT OUTSTANDING INDEBTEDNESS;
OUR AGREEMENTS WITH OUR LENDERS RESTRICT OUR OPERATING FLEXIBILITY

        The Company has entered into a loan and security agreement with a
financial institution whereby the Company obtained a secured $17 million
revolving line of credit and term loan facility. On December 31, 1998
approximately $15,300,000 was outstanding under this facility. This facility,
which expires in November 1999, bears interest at the lending institution's
prime rate plus 1% per annum and is secured by the Company's cash, cash
equivalents, marketable securities, accounts receivable inventory, equipment and
all other tangible and intangible assets and a pledge of all the common stock of
the Company's wholly-owned subsidiaries. Additionally, the facility contains
certain affirmative and negative covenants which require the Company to maintain
a certain net worth, and, among other things, restrict (i) the declaration or
payment of dividends, (ii) the incurrence of additional indebtedness and (iii)
the sale of certain assets. There can be no assurance that the Company will be
able to remain in compliance with such covenants in the future. The Company is
currently in compliance with all restrictive covenants and other material
provisions of the facility.


                                       3


<PAGE>


WE COMPETE IN A HIGHLY COMPETITIVE INDUSTRY

        The custom display segment of the in-store marketing industry in which
the Company primarily competes is highly competitive. Certain of the Company's
competitors, including several diversified companies, not only design and
assemble merchandising systems for their own products, but also provide these
systems and services to unaffiliated concerns. Our competitors may have greater
financial and other resources than the Company which may provide our competitors
with certain advantages, including the ability to spend greater resources for
research and development, marketing and other purposes. In addition, although
the Company believes that it has certain creative, design, technological,
managerial and other advantages over certain of its competitors, there can be no
assurance that the Company will maintain such advantages.

THE MARKET PRICE OF OUR COMMON STOCK CAN BE HIGHLY VOLATILE

        The average daily trading volume of our common stock has generally been
low, which the Company believes has had a significant effect on the historical
market price of our common stock. As a result, such market price has been highly
volatile and may not be indicative of the market price in a more liquid market.
The market price of our common stock could be subject to significant
fluctuations in response to a number of factors, including the depth and
liquidity of the market for the common stock, public announcements by the
Company, its clients and its competitors, investor perception of the Company and
general economic and other conditions, which may or may not relate to the
Company's performance.

CERTAIN OFFICERS AND DIRECTORS OWN A SUBSTANTIAL PORTION OF OUR COMMON STOCK

        As of June 1, 1999, the Company's executive officers and directors
beneficially owned approximately 37.55% of our common stock. Consequently, the
Company's executive officers and directors will have substantial influence on
the outcome of any matters submitted to the Company's stockholders for approval,
including the election of directors. Such concentration of ownership may also
have the effect of preventing a change in control of the Company. In addition,
the interests of management may not always be identical to the interests of the
non-management stockholders.

WE ARE UNLIKELY TO PAY DIVIDENDS FOR THE FORSEEABLE FUTURE

        The Company has not paid dividends on the common stock since its
inception. The Company intends to reinvest any earnings in its business to
finance future growth. Accordingly, the Board of Directors does not anticipate
declaring any cash dividends in the foreseeable future. In addition, under the
terms of our financing facility, the Company is prohibited from paying cash
dividends.

POTENTIAL DILUTIVE EFFECT OF SHARES ELIGIBLE FOR FUTURE SALE

        As of June 1, 1999, the Company had outstanding 11,111,605 shares of
common stock. An aggregate of 5,168,428 shares of common stock will become
outstanding upon the exercise or conversion, as the case may be, of all of the
stock options and warrants outstanding at June 1, 1999. No prediction can be
made as to the effect, if any, that sales of shares of common stock at a
discount to the market price will have on the market price of the Company's
securities prevailing from time to time. The possibility that substantial
amounts of common stock may be sold under Rule 144 into the public market may
adversely affect the prevailing market price for the common stock and could
impair the Company's ability to raise capital in the future through the sale of
equity securities. Moreover, a total of 1,515,000 of such shares which are
issuable upon the exercise of the stock options and warrants are being
registered for resale pursuant to the Registration Statement.

                                 USE OF PROCEEDS

        The shares of common stock being offered hereby are for the account of
the selling stockholders. Accordingly, the Company will not receive any of the
proceeds from the sale of shares of common stock by the selling stockholders.
The Company will receive proceeds of up to $2,913,125 upon the exercise of the
options and warrants held by the selling stockholders if such selling
stockholders decide to exercise them. The proceeds from the exercise of the
options and warrants would be used for working capital. See "Selling
Stockholders."



                                       4


<PAGE>

                         SELLING STOCKHOLDERS

         The following table sets forth certain information with respect to
selling stockholders. The number of shares of common stock that may actually be
sold by the selling stockholders will be determined by such selling
stockholders, and may depend upon a number of factors, including, among other
things, the market price of the Common Stock. The table below sets forth
information as of the date of this prospectus, concerning the beneficial
ownership of Common Stock of the selling stockholders including those of the
Company directors and officers. All information concerning beneficial ownership
has been furnished by the selling stockholders.

<TABLE>
<CAPTION>

                                               SHARES OF COMMON STOCK       SHARES OF       SHARES OF COMMON STOCK
                                                        OWNED                COMMON                 OWNED
                                                   BEFORE OFFERING        STOCK OFFERED       AFTER OFFERING(3)
                                                   ---------------        -------------       --------------
                                               NUMBER(1)   PERCENT(2)        NUMBER         NUMBER(3)   PERCENT(3)
                                               ------      -------           ------         ------      -------
<S>                                           <C>            <C>           <C>              <C>         <C>
Michael Wahl(4)                                1,376,725(5)   12.5           90,000
Andrew Wahl(6)                                   957,803(7)    8.6           90,000
Robert V. Cuddihy, Jr.(8)                        459,408(9)    4.2           90,000
Herbert F. Kozlov(10)                            305,476(11)   2.8           90,000
L. Randy Riley(12)                               429,194(13)   3.9           90,000
Lawrence J. Twill, Sr.(14)                       186,150(15)   1.7           90,000
Ivan Berkowitz(16)                               234,250(17)   2.1          151,250
Louis Perlman(18)                                113,000(19)   1.0           30,000
BNY Capital Markets(20)                          218,750(21)   2.0          218,750
The Yitz Grossman Charitable Trust                50,000(22)    *            50,000
Steven Markowitz                                  50,000(22)    *            50,000
Joseph Sorbara                                    50,000(22)    *            50,000
Robert Merkel(24)                                 50,000(25)    *            50,000
Stephen Dopp(24)                                 100,000(25)    *           100,000
Parker Duryee Rosoff & Haft                       50,000(26)    *            50,000
Marc Roberts(27)                                  25,000(23)    *            25,000
HMG Capital Accumulation Plan                     74,252        *            74,252
Dogwood Associates                               200,000(22)   1.8          200,000
Joseph Stevens & Company                         100,000(22)    *           100,000
Gennadiy Rodionoy                                100,000(22)    *           100,000

</TABLE>
- --------------
* less than 1%

                                          5


<PAGE>

 (1) Represents those shares of Common Stock held by the Selling Stockholders
     together with those shares that such Selling Stockholder has the right to
     acquire within 60 days from the date of this Prospectus including, without
     limitation, shares issuable upon exercise of the options and warrants.

 (2) The percentages indicated assume that all options and warrants were
     exercised and the Shares purchased thereunder were issued immediately prior
     to the date of this Prospectus.

 (3) Because the Selling Stockholders may sell all, some or none of the Shares
     that he, she or it holds, and because the offering contemplated by this
     Prospectus is not a "firm commitment" underwritten offering, no estimate
     can be given as to the number of Shares that will be held by any of the
     Selling Stockholders upon or prior to termination of this offering. See
     "Plan of Distribution."

 (4) Mr. Wahl is Chairman of the Board, Chief Executive Officer and a Director
     of the Company.

 (5) Includes 694,828 shares issuable upon exercise of options.

 (6) Mr. Wahl is the President and a Director of the Company.

 (7) Includes 611,750 shares issuable upon exercise of options.

 (8) Mr. Cuddihy is the Chief Operating Officer, Chief Financial Officer and a
     Director of the Company.

 (9) Includes 318,850 shares issuable upon exercise of options.

(10) Mr. Kozlov is a Director of the Company.

(11) Includes 287,600 shares issuable upon exercise of options.

(12) Mr. Riley is the Executive Vice President and a Director of the Company.

(13) Includes 318,850 shares issuable upon exercise of options.

(14) Mr. Twill is a Director of the Company.

(15) Includes 175,400 shares issuable upon exercise of options.

(16) Mr. Berkowitz is the President of Great Court Analysis LLC which
     beneficially owned 640,000 shares.

(17) Includes 203,000 shares issuable upon exercise of options and warrants.

(18) Mr. Perlman was a director of the Company from January 1998 until his
     resignation on May 13, 1998.

(19) Represents shares issuable upon exercise of options.

(20) BNY Capital Markets serves as a consultant to the Company.

(21) Represents shares issuable upon exercise of warrants.

(22) Represents shares issued pursuant to a December 1998 private placement,
     all of which are being offered hereunder.

(23) Represents shares issuable upon exercise of warrants, all of which are
     being offered hereunder.

(24) Selling Stockholder is an employee of the Company.

(25) Represents shares issuable upon exercise of the options.

(26) Does not include 305,476 shares of Common Stock beneficially owned by
     Herbert Kozlov, a member of Parker Duryee Rosoff & Haft, P.C., and a
     Director of the Company and 6,000 shares of Common Stock beneficially
     owned by two other members of Parker Duryee Rosoff & Haft, P.C.

(27) Mr. Roberts is a consultant to the Company.

     Pursuant to certain agreements between the Company and the selling
stockholders, the Company has agreed (i) to file the registration statement of
which this prospectus forms a part for the purpose of registering the potential
resale of the shares; and (ii) to bear all expenses of the registration and sale
of the shares (other than any underwriting discounts and conversions).

                           PLAN OF DISTRIBUTION

         Sales of the shares may be made from time to time by the selling
stockholders, or, subject to applicable law, by pledges, donees, distributees,
transferees or other successors in interest. Such sales may be made on The
Nasdaq SmallCap Market, in another over-the-counter market, on a national
securities exchange (any of which may involve crosses and block transactions),
in privately negotiated transactions or otherwise or in a combination of such
transactions at prices and at terms then prevailing or at prices related to the
then current market price, or at privately negotiated prices. In addition, any
shares covered by this Prospectus which qualify for sale pursuant to Section
4(1) of the Securities Act of 1933 or Rule 144 promulgated thereunder may be
sold under such provisions rather than pursuant to this prospectus. Without
limiting the generality of the foregoing, the shares may be sold in one or more
of the following types of transactions: (a) a block trade in which the
broker-dealer so engaged will attempt to sell the shares as agent but may
position and resell a portion of the block as principal to facilitate the
transaction; (b) purchases by a broker or dealer as principal; (c) an exchange
distribution in accordance with the rules of such exchange; (d) ordinary
brokerage transactions and transactions in which the broker solicits purchasers;
and (e) face-to-face transactions between sellers and purchasers without a
broker-dealer. In effecting sales, brokers or dealers engaged by the selling
stockholder may arrange for other brokers or dealers to participate in the
resales.

                                    6


<PAGE>


        In connection with distributions of the shares or otherwise, the selling
stockholders may enter into hedging transactions. In connection with hedging
transactions, participants may engage in short sales of the shares registered
hereunder in the course of hedging the positions they assume with the selling
stockholders. The selling stockholders may also sell shares short and deliver
the shares to close out such short positions. The selling stockholders may also
enter into option or other transactions. The selling stockholders may also
pledge the shares registered hereunder to a broker or dealer and upon a default,
the pledgor may effect sales of the pledged shares pursuant to this prospectus.

        Brokers, dealers or agents may receive compensation in the form of
commissions, discounts or concessions from selling stockholder in amounts to be
negotiated in connection with the sale. Such brokers or dealers and any other
participating brokers or dealers may be deemed to be "underwriters" within the
meaning of the Securities Act of 1933 in connection with sales and any
commission, discount or concession may be deemed to be underwriting discounts or
commissions under the Securities Act of 1933.

        Information as to whether underwriters who may be selected by the
selling stockholders, or any other broker-dealer, is acting as principal or
agent for the selling stockholder, the compensation to be received by
underwriters who may be selected by the selling stockholders, or any
broker-dealer, acting as principal or agent for the selling stockholders and the
compensation to be received by other broker-dealers, in the event the
compensation of such other broker-dealers is in excess of usual and customary
commissions, will, to the extent required, be set forth in a supplement to this
prospectus. Any dealer or broker participating in any distribution of the shares
may be required to deliver a copy of this prospectus, including the prospectus
supplement, if any, to any person who purchases any of the shares from or
through such dealer or broker.

        The Company has advised the selling stockholders that during such time
as they may be engaged in a distribution of the shares included herein they are
required to comply with Regulation M promulgated under the Exchange Act of 1934.
In general, Regulation M precludes the selling shareholders, any affiliated
purchasers and any broker-dealer or other person who participates in such
distribution from bidding for or purchasing, or attempting to induce any person
to bid for or purchase any security which is the subject of the distribution
until the entire distribution is complete. A "distribution" is defined in the
rules as an offering of securities that is distinguished from ordinary trading
activities and depends on the "magnitude of the offering and the presence of
special selling efforts and selling methods." Regulation M also prohibits any
bids or purchases made in order to stabilize the price of a security in
connection with the distribution of that security.

    It is anticipated that the selling stockholders will offer all of the shares
for sale. Further, because it is possible that a significant number of shares
could be sold at the same time hereunder, any sales, or the possibility thereof,
may depress the market price of the common stock.

                                  LEGAL MATTERS

    Certain legal matters in connection with the shares of common stock being
offered hereby will be passed upon for the Company by Parker Duryee Rosoff &
Haft, New York, New York 10017. Parker Duryee Rosoff & Haft owns 50,000 shares
of common stock which may be offered by such firm pursuant to this Prospectus.
In addition, members of Parker Duryee Rosoff & Haft beneficially own an
aggregate of 311,476 shares of common stock as of June 1, 1999, including
305,476 shares that are beneficially owned by Herbert F. Kozlov, a member of
such Firm and a director of the Company.

                                     EXPERTS

    The consolidated financial statements of the Company included in the
Company's annual report on Form 10-K for the year ended December 31, 1998
incorporated herein by reference have been audited by Friedman Alpren & Green
LLP, independent certified public accountants, as indicated in their report with
respect thereto, and are incorporated herein by reference in reliance upon the
report of said firm given upon their authority as experts in accounting and
auditing.

                                       7




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission